Japan Health Ministry Cancels Haruna Kawaguchi Film Poster Tie-Up After Cancer Patient Backlash

On Monday, August 24, 2026, Japan’s Ministry of Health, Labour and Welfare (MHLW) canceled a promotional tie-up with actress Haruna Kawaguchi’s upcoming film “Even If Mom Is No Longer in This World: My Life Diary” and issued a public apology. Cancer patients, survivors, and families had criticized hospital-displayed posters for the campaign as insensitive to people still in treatment.

The ministry had unveiled the partnership on August 19 to promote support services for the AYA (Adolescent and Young Adult) generation — people diagnosed with cancer between ages 15 and 39. Within days, social media and patient advocates objected to placing the film’s death-implying title in oncology settings.

Editor’s note: This article draws on MHLW statements, reporting by Sankei Shimbun (via Tokyo Reporter), ORICON NEWS, J-CAST News, and NHK-linked domestic coverage, August 19–24, 2026.

What the campaign was meant to do

The tie-up was designed to raise awareness of a government pamphlet titled “To You Diagnosed with Cancer in Your Teens and Twenties–Thirties: A Guide to Systems Supporting Cancer Treatment and Daily Life.” It summarized benefits, counseling desks, and Cancer Consultation Support Centers available to young patients and their families.

Element	Detail
Announced	August 19, 2026
Film release	October 2, 2026
Lead actress	Haruna Kawaguchi
Target audience	AYA cancer patients (ages 15–39) and families
Outreach	Posters, dedicated web page, social posts on @MHLWitter
Planned placement	Hospitals and cancer-treatment facilities

The film is based on the true story of a woman who received a stage IV colon cancer diagnosis at 21 and documented her life with loved ones. Supporters of the movie itself note that it portrays love and resilience; the controversy centered on where and how the title was promoted, not on the film’s artistic intent.

Why patients and doctors pushed back

When MHLW posted sample posters online, reactions from patients, survivors, and clinicians were swift. Common complaints included:

• Reading “Even if Mom is no longer in this world” inside a hospital felt psychologically crushing for people fighting to live.
• The pairing of a grief-laden title with the line “To you who were diagnosed with cancer in the AYA generation” read as if the ministry were addressing patients as though death were assumed.
• Oncology wards are places where people receive chemotherapy and hope for remission; critics said the messaging ignored that daily reality.

Comments circulating on X included pleas such as “Don’t put this in hospitals” and “We come to hospitals to keep living.” Medical workers and AYA survivors argued the ministry had failed basic stakeholder review before printing and distributing materials.

Political response

Makoto Sasaki, a member of the House of Representatives from the Democratic Party for the People and a cancer survivor diagnosed with malignant lymphoma at 26, criticized the campaign on X.

“As someone who has been through this, I feel a strong sense of discomfort,” she wrote, calling on the ministry to reconsider the poster’s wording and placement. Speaking to Sankei Shimbun, Sasaki said she intended to examine how the project cleared internal approval.

Her intervention highlighted a broader question: whether government health agencies adequately consult lived experience when designing patient-facing communications.

MHLW apology and withdrawal

By August 24, MHLW moved from reviewing complaints to ending the partnership outright.

On its official website and X account, the ministry said:

“We sincerely and deeply apologize for causing discomfort to patients fighting cancer and their families.”

Key steps announced:

1. Full cancellation of the film tie-up.
2. Instructions to medical institutions that already received posters not to display them.
3. Removal of tie-up-related social media posts and web content tied to the campaign.

MHLW acknowledged that its outreach “lacked consideration for those concerned” and that vetting had been insufficient. A ministry spokesperson told J-CAST News that the production company had originally proposed the collaboration and that staff believed it aligned with cancer-policy promotion — but that the ministry now recognized problems with placement and messaging once posters reached the public.

Haruna Kawaguchi and the film

Haruna Kawaguchi is a prominent Japanese actress whose credits span film and television. “Even If Mom Is No Longer in This World: My Life Diary” (“Mama ga Mou Kono Sekai ni Inakutemo, Watashi no Inochi Nikki” in Japanese) remains scheduled to open in theaters on October 2.

Public backlash focused on the government publicity partnership, not on Kawaguchi’s casting. As of August 24, major reports centered on MHLW’s withdrawal rather than statements from the actress or distributor about the ministry’s decision.

The film’s source material — a real patient’s diary — deals openly with terminal illness. Advocates who defended the project’s educational goal argued that AYA patients can benefit from seeing their experiences reflected on screen. Opponents countered that a theatrical title carrying different emotional weight should not be pasted on clinic walls without careful framing.

Broader context: government tie-up scrutiny

The Kawaguchi poster dispute arrived in the same week as another Japanese ministry retreat from a pop-culture partnership. On August 21, the Justice Ministry scrapped a tie-up with the Netflix reality series “Love Joto” after a cast member’s on-air remarks about violence drew public outrage.

Together, the episodes renewed debate over how ministries choose entertainment collaborators, how fast social feedback can force reversals, and whether civil-service communications teams need stronger sensitivity review before materials reach hospitals.

What happens next

MHLW said it would continue promoting AYA cancer support programs through channels that do not rely on the withdrawn posters. Hospitals told to hold undisplayed materials await further guidance on disposal or return.

Lawmakers including Sasaki may press for details on who signed off on the August 19 launch. For patients and families, the immediate outcome is simpler: the disputed posters should not appear in treatment settings.

---

Discussion

Government health campaigns walk a narrow line between visibility and respect for people in crisis.

1. Can a film about terminal illness ever be the right face of a hospital awareness campaign?

The movie tells a true story of courage; the title also evokes loss. Where should ministries draw the line between promotion and patient comfort?

2. Who should sign off before patient-facing materials go to print?

MHLW admitted its review was inadequate. Should cancer survivors, nurses, and AYA counselors have mandatory veto power over wording and placement?

If you or someone close to you has navigated cancer care in Japan, what message would you want to see on a clinic wall?